Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share (the "Common Stock")
-
Shares outstanding
-
62,650,155
-
Total 13F shares
-
58,165,463
-
Share change
-
+247,869
-
Total reported value
-
$8,160,782,684
-
Put/Call ratio
-
126%
-
Price per share
-
$140.29
-
Number of holders
-
269
-
Value change
-
+$20,674,357
-
Number of buys
-
133
-
Number of sells
-
120
Institutional Holders of Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE) as of Q3 2019
As of 30 Sep 2019,
Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE) was held by
269 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
58,165,463 shares.
The largest 10 holders included
FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, Capital International Investors, JENNISON ASSOCIATES LLC, BlackRock Inc., JANUS HENDERSON GROUP PLC, WELLINGTON MANAGEMENT GROUP LLP, Invesco Ltd., and Bellevue Group AG.
This page lists
270
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.